Repare Therapeutics Inc (NASDAQ: RPTX) is -2.29% lower on its value in year-to-date trading and has touched a low of $1.20 and a high of $8.49 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The RPTX stock was last observed hovering at around $1.28 in the last trading session, with the day’s loss setting it 0.0%.
Currently trading at $1.28, the stock is -2.74% and -46.15% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.19 million and changing 0.00% at the moment leaves the stock -59.46% off its SMA200. RPTX registered -79.15% loss for a year compared to 6-month loss of -67.51%. The firm has a 50-day simple moving average (SMA 50) of $2.3771 and a 200-day simple moving average (SMA200) of $3.157375.
The stock witnessed a -20.00% gain in the last 1 month and extending the period to 3 months gives it a -62.57%, and is -7.25% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 6.76% over the week and 9.06% over the month.
Repare Therapeutics Inc (RPTX) has around 179 employees, a market worth around $54.41M and $66.52M in sales. Profit margin for the company is -126.34%. Distance from 52-week low is 6.67% and -84.92% from its 52-week high. The company has generated returns on investments over the last 12 months (-47.94%).
with sales reaching $2.73M over the same period.The EPS is expected to grow by 3.89% this year, but quarterly earnings will post 8.98% year-over-year. Quarterly sales are estimated to shrink -79.05% in year-over-year returns.
Repare Therapeutics Inc (RPTX) Top Institutional Holders
72.0 institutions hold shares in Repare Therapeutics Inc (RPTX), with institutional investors hold 84.23% of the company’s shares. The shares outstanding are 42.51M, and float is at 30.02M with Short Float at 4.34%. Institutions hold 83.43% of the Float.
The top institutional shareholder in the company is BVF INC/IL with over 10.33 million shares valued at $34.1 million. The investor’s holdings represent 24.4675% of the RPTX Shares outstanding. As of 2024-06-30, the second largest holder is BLUE OWL CAPITAL HOLDINGS LP with 3.37 million shares valued at $11.13 million to account for 7.9853 of the shares outstanding. The other top investors are ORBIMED ADVISORS LLC which holds 3.32 million shares representing 7.8669% and valued at over $10.96 million, while VERSANT VENTURE MANAGEMENT, LLC holds 6.2666 of the shares totaling 2.65 million with a market value of $8.73 million.
Repare Therapeutics Inc (RPTX) Insider Activity
The most recent transaction is an insider sale by Segal Lloyd Mitchell, the company’s PRESIDENT AND CEO. SEC filings show that Segal Lloyd Mitchell sold 2,650 shares of the company’s common stock on Mar 28 ’24 at a price of $4.62 per share for a total of $12243.0. Following the sale, the insider now owns 0.11 million shares.
Repare Therapeutics Inc disclosed in a document filed with the SEC on Apr 01 ’24 that Segal Lloyd Mitchell (PRESIDENT AND CEO) sold a total of 2,491 shares of the company’s common stock. The trade occurred on Apr 01 ’24 and was made at $4.63 per share for $11533.0. Following the transaction, the insider now directly holds 0.11 million shares of the RPTX stock.
Still, SEC filings show that on Mar 28 ’24, Forte Steve (EVP, CHIEF FINANCIAL OFFICER) disposed off 825 shares at an average price of $4.62 for $3812.0. The insider now directly holds 45,564 shares of Repare Therapeutics Inc (RPTX).
